Related Experiment Video
Updated: Oct 6, 2025

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives
Cristina Martín-Sabroso1,2, Ana Isabel Torres-Suárez1,2, Mario Alonso-González1
1Department of Pharmaceutics and Food Technology, School of Pharmacy, Complutense University, 28040 Madrid, Spain.
Abstract:
In normal tissues, the expression of folate receptors is low and limited to cells that are important for embryonic development or for folate reabsorption. However, in several pathological conditions some cells, such as cancer cells and activated macrophages, overexpress folate receptors (FRs). This overexpression makes them a potential therapeutic target in the treatment of cancer and inflammatory diseases to obtain a selective delivery of drugs at altered cells level, and thus to improve the therapeutic efficacy and decrease the systemic toxicity of the pharmacological treatments. Two strategies have been used to achieve this folate receptor targeting: (i) the use of ligands with high affinity to FRs (e.g., folic acid or anti-FRs monoclonal antibodies) linked to the therapeutic agents or (ii) the use of nanocarriers whose surface is decorated with these ligands and in which the drug is encapsulated. This manuscript analyzes the use of FRs as a target to develop new therapeutic tools in the treatment of cancer and inflammatory diseases with an emphasis on the nanoformulations that have been developed for both therapeutic and imaging purposes.
Insights
Folate receptors (FRs) are overexpressed in cancer and inflammatory diseases, making them a promising therapeutic target. Targeting FRs with ligands or nanocarriers offers improved drug delivery and reduced toxicity for these conditions.
Area of Science:
- Biomedical Science
- Drug Delivery
- Nanotechnology
Background:
- Folate receptors (FRs) exhibit low expression in normal tissues but are overexpressed in cancer cells and activated macrophages.
- This overexpression presents a therapeutic opportunity for targeted drug delivery in pathological conditions.
Purpose of the Study:
- To analyze the use of folate receptors (FRs) as a target for novel therapeutic strategies.
- To explore nanoformulations for targeted drug delivery and imaging in cancer and inflammatory diseases.
Main Methods:
- Review of strategies for folate receptor targeting, including high-affinity ligands (folic acid, monoclonal antibodies) and ligand-decorated nanocarriers.
- Analysis of nanoformulations for therapeutic and imaging applications targeting FRs.
Main Results:
- Folate receptor targeting enables selective drug delivery to cancer cells and activated macrophages.
- Nanoformulations enhance therapeutic efficacy and reduce systemic toxicity of treatments.
- Targeted approaches show potential for both therapeutic intervention and diagnostic imaging.
Conclusions:
- Folate receptor targeting is a viable strategy for developing advanced therapeutics for cancer and inflammatory diseases.
- Nanoformulations offer a promising platform for FR-targeted drug delivery and imaging, improving treatment outcomes.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Signal Transduction: Overview
Typically, signal transduction involves three...
Drugs that Stabilize Microtubules

